Discontinuation report TEVA-NAPROXEN
Report ID | 14055 |
Drug Identification Number | 00565350 |
Brand name | TEVA-NAPROXEN |
Common or Proper name | NAPROXEN |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | NAPROXEN |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 U/D |
ATC code | M01AE |
ATC description | ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | |
Actual discontinuation date | 2017-04-07 |
Remaining supply date | 2017-04-07 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | BOTTLES AVAILABLE |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-06-27 | French | Compare |
v1 | 2017-06-27 | English | Compare |
Showing 1 to 2 of 2